Oral Androgens in Man-7: Pharmacokinetics of a Novel Oral Testosterone Undecanoate Formulation With Concomitant Inhibition of 5alpha-Reductase by Finasteride.
Phase of Trial: Phase II
Latest Information Update: 23 Apr 2010
At a glance
- Drugs Finasteride (Primary) ; Testosterone undecanoate (Primary) ; Acyline
- Indications Alopecia; Benign prostatic hyperplasia; Prostate cancer
- Focus Pharmacokinetics
- 23 Apr 2010 Actual end date (Nov 2009) added as reported by ClinicalTrials.gov.
- 23 Apr 2010 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 24 Oct 2009 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.